Mid Ohio Oncology/Hematology Mark H. Zangmeister Center — Columbus, Ohio

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center has participated in 1 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Columbus

Browse all research sites in Ohio · View every site in Columbus

• Ohio State University Wexner Medical Center - Outpatient Care East
• Division of Radiation Oncology, The Ohio State University Wexner
• Mount Caramel East Hospital
• The Ohio State University Wexner Medical Center - Martha Morehouse Medical Pavilion
• The Wright Center of Innovation- The Ohio State University
• Ohio State University Wexner Medical Center: Division of Nephrology
• The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute
• The University of Ohio
• University Hospital East Ohio State University Medical Center
• Division of Cardiology - The Ohio State University Medical Center
• Ohio State University Med Ctr; MS Center
• Ohio State University, Ohio State University Medical Center The Richard M Ross Heart Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Ohio Oncology/Hematology Mark H. Zangmeister Center?

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Ohio Oncology/Hematology Mark H. Zangmeister Center conducted?

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center has 1 clinical trials on record. Their work covers PI3K Pathway Activated Tumors.

Is Mid Ohio Oncology/Hematology Mark H. Zangmeister Center accredited by Crixeo Clinical Trials?

Mid Ohio Oncology/Hematology Mark H. Zangmeister Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Ohio Oncology/Hematology Mark H. Zangmeister Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.